Article

Pediatric Patients With Irritable Bowel Syndrome Have Vitamin D Deficiency

Author(s):

A vitamin D deficit may be linked with irritable bowel syndrome (IBS) in children. According to a new study published in PLOS ONE, more than 90% of pediatric patients with IBS were deficient in vitamin D.

A vitamin D deficit may be linked with irritable bowel syndrome (IBS) in children. According to a new study published in PLOS ONE, more than 90% of pediatric patients with IBS were deficient in vitamin D.

Researchers analyzed medical records of patients between the ages of 6 and 21 years with a diagnosis of IBS and compared them with healthy children in a control group. None of the controls had IBS, irritable bowel disease, or celiac disease; nor were they receiving vitamin D supplementation or steroid therapy. Vitamin D deficiency was found to be more prevalent among children with IBS compared with those who had irritable bowel disease.

“I was surprised that IBS had the highest prevalence of vitamin D deficiency of all the gastrointestinal disorders we studied in the past 5 years,” study author Benjamin U. Nwosu, MD, said in a statement. “The primary finding from this study is that 1 out of every 2 pediatric patients with IBS has vitamin D deficiency compared to 1 out of every 4 healthy children and adolescents without IBS. The importance of this study was to initiate the first steps in the critical assessment of the role of vitamin D as an adjunctive therapy in children and adolescents with IBS.”

The researchers also investigated the relationship between vitamin D and anxiety, depression, and migraine headaches, all of which are symptoms that accompany IBS. According to the analysis, children with IBS and migraine had significantly lower vitamin D levels compared with the control patients.

The study’s findings suggest that it may be worthwhile to consider vitamin D as an adjunctive therapy in pediatric patients with IBS, but more studies are needed, the authors wrote.

“With more than 90% of children with IBS being vitamin D deficient, they are definitely at risk for decreased bone mass,” Nwosu said. “Clinicians should immediately increase their surveillance for vitamin D deficiency in patients with IBS and initiate appropriate vitamin D supplementation in cases of deficiency. Future research studies will explore the effect of vitamin D deficiency on bone mass and other associated pathologies in IBS. This paper strengthens the case for a vitamin D screening and supplementation protocol for all patients with IBS.”

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
4 KOLs are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo